User profiles for Oladayo A. Oyebanji

Oladayo A. Oyebanji

Case Western Reserve University
Verified email at case.edu
Cited by 278

[HTML][HTML] COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents

DH Canaday, OA Oyebanji, E White, D Keresztesy… - …, 2022 - thelancet.com
Background Nursing home (NH) residents have borne a disproportionate share of SARS-CoV-2
morbidity and mortality. Vaccines have limited hospitalisation and death from earlier …

Reduced BNT162b2 messenger RNA vaccine response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents

DH Canaday, L Carias, OA Oyebanji… - Clinical Infectious …, 2021 - academic.oup.com
After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding
domain, and virus neutralization were examined in 149 nursing home residents and 110 …

[HTML][HTML] Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents

DH Canaday, L Carias, OA Oyebanji, D Keresztesy… - medRxiv, 2021 - ncbi.nlm.nih.gov
The SARS-CoV-2 pandemic impact on nursing home (NH) residents prompted their prioritization
for early vaccination. To fill the data gap for vaccine immunogenicity in NH residents, …

Significant reduction in vaccine-induced antibody levels and neutralization activity among healthcare workers and nursing home residents 6 months following …

DH Canaday, OA Oyebanji, D Keresztesy… - Clinical Infectious …, 2022 - academic.oup.com
Antibody decline occurred from 2 weeks to 6 months post-BNT162b2 mRNA vaccination in
nursing home (NH) residents and healthcare workers. Antispike, receptor-binding domain, …

[HTML][HTML] Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?

OA Oyebanji, B Wilson, D Keresztesy, L Carias… - Aging clinical and …, 2021 - Springer
Background The BNT162b2 SARS-CoV-2 mRNA vaccination has mitigated the burden of
COVID-19 among residents of long-term care facilities considerably, despite being excluded …

[HTML][HTML] Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination

DH Canaday, OA Oyebanji, E White, D Keresztesy… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Nursing home (NH) residents have experienced significant morbidity and mortality to SARS-CoV-2
throughout the pandemic. Vaccines initially curbed NH resident morbidity and …

[HTML][HTML] Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers

…, M Kaczynski, LO Felix, N Ganesan, OA Oyebanji… - Vaccine, 2023 - Elsevier
We examined whether the second monovalent SARS-CoV-2 mRNA booster increased
antibody levels and their neutralizing activity to Omicron variants in nursing home residents (NH) …

[HTML][HTML] Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination

S Gravenstein, F DeVone, OA Oyebanji, Y Abul, Y Cao… - medRxiv, 2023 - ncbi.nlm.nih.gov
Background: Vaccines have substantially mitigated the disproportional impact of SARS-CoV-2
on the high morbidity and mortality experienced by nursing home residents. However, …

Significant reduction in humoral Immunity among healthcare workers and nursing home residents 6 months AFTER COVID-19 BNT162b2 mRNA vaccination

DH Canaday, OA Oyebanji, D Keresztesy, M Payne… - MedRxiv, 2021 - medrxiv.org
High COVID-19 mortality among nursing home (NH) residents led to their prioritization for
SARS-CoV-2 vaccination; most NH residents received BNT162b2 mRNA vaccination under …

Vaccines for the prevention of coronavirus disease 2019 in older adults

OA Oyebanji, E Mylonakis… - Infectious Disease Clinics, 2023 - id.theclinics.com
Institutionalized and community-dwelling older adults have been greatly impacted by the
coronavirus disease 2019 (COVID-19) pandemic. 1 Older adults have a higher incidence of …